Production (Stage)
ABVC BioPharma, Inc.
ABVC
$1.15
-$0.06-4.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -842.10K | 229.30K | -186.60K | -1.01M | -2.83M |
| Total Depreciation and Amortization | 113.90K | 179.30K | 7.00K | 13.30K | 102.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 207.60K | -681.70K | 338.70K | 475.30K | 2.11M |
| Change in Net Operating Assets | -19.30K | -220.60K | 12.60K | -490.00K | -338.60K |
| Cash from Operations | -539.80K | -493.60K | 171.70K | -1.01M | -955.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 689.60K | 0.00 | 0.00 | 312.10K |
| Total Debt Repaid | -29.30K | -177.00K | -179.10K | -- | -- |
| Issuance of Common Stock | 411.70K | 76.30K | 33.70K | 868.50K | -- |
| Repurchase of Common Stock | -- | -7.30K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.30K | 0.00 | 0.00 | 0.00 | 612.10K |
| Cash from Financing | 428.80K | 581.50K | -145.40K | 868.50K | 924.10K |
| Foreign Exchange rate Adjustments | 6.80K | 6.10K | 800.00 | 229.30K | -26.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.20K | 93.90K | 27.10K | 83.80K | -57.80K |